Tegafur/gimeracil/oteracil (TS-1) induced Stevens-Johnson syndrome: Case report

• Egile Nagusiak: Satoko Minakawa (Egilea), Yasushi Matsuzaki (Egilea), Koji Nakajima (Egilea), Hajime Nakano (Egilea), Daisuke Sawamura (Egilea)
• Formatua: Liburua
• Argitaratua: Wolters Kluwer Medknow Publications, 2013-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

TS-1 is an oral fluoropyrimidine anticancer drug that contains tegafur, gimeracil, and oteracil. A 78-year-old Japanese male who was diagnosed with carcinoma of the oral floor (rT4aN0M0) was prescribed a standard dose of TS-1 (80 mg/day). On Day 8 after administration of TS-1, an eruption developed....